Efficacy and Tolerability of Metamizol in Patients With Episodic Moderate Headache

Clinical trial NCT02183220 · COMPLETED

Trial details

NCT number: NCT02183220
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Migraine Disorders

Start date: 1998-10-01
Primary completion: 1999-07-01
Enrollment: 417

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.